Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR.

Diabetologia. 2012 Jun;55(6):1577-96. doi: 10.1007/s00125-012-2534-0. Epub 2012 Apr 20. No abstract available. Erratum in: Diabetologia. 2013 Mar;56(3):680.

PMID:
22526604
2.

Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.

Jeon HJ, Oh TK.

Diabetes Metab J. 2011 Oct;35(5):529-35. doi: 10.4093/dmj.2011.35.5.529. Epub 2011 Oct 31.

3.

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study.

Matthews DR, Dejager S, Ahren B, Fonseca V, Ferrannini E, Couturier A, Foley JE, Zinman B.

Diabetes Obes Metab. 2010 Sep;12(9):780-9. doi: 10.1111/j.1463-1326.2010.01233.x.

PMID:
20649630
4.

The role of glimepiride in the treatment of type 2 diabetes mellitus.

Briscoe VJ, Griffith ML, Davis SN.

Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):225-35. doi: 10.1517/17425250903512955. Review.

PMID:
20055691
5.

Coordinated regulation of esterification and lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes.

Müller G, Wied S, Straub J, Jung C.

Eur J Pharmacol. 2008 Nov 12;597(1-3):6-18. doi: 10.1016/j.ejphar.2008.08.034. Epub 2008 Sep 3.

PMID:
18789917
6.

Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus.

Fonseca V, Baron M, Shao Q, Dejager S.

Horm Metab Res. 2008 Jun;40(6):427-30. doi: 10.1055/s-2008-1058090. Epub 2008 Mar 11. No abstract available.

PMID:
18401832
7.

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.

Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA.

Diabetes Obes Metab. 2008 Nov;10(11):1047-56. doi: 10.1111/j.1463-1326.2008.00859.x. Epub 2008 Feb 18.

PMID:
18284434
8.

Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.

Rosenstock J, Fitchet M.

Int J Clin Pract Suppl. 2008 Mar;(159):15-23. doi: 10.1111/j.1742-1241.2007.01692.x. Review.

PMID:
18269437
9.
12.

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients.

Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM.

Eur J Clin Invest. 2004 Aug;34(8):535-42.

PMID:
15305887
13.

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Wild S, Roglic G, Green A, Sicree R, King H.

Diabetes Care. 2004 May;27(5):1047-53.

PMID:
15111519
14.

Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.

Shukla UA, Chi EM, Lehr KH.

Ann Pharmacother. 2004 Jan;38(1):30-5.

PMID:
14742789
15.

Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.

Martin S, Kolb H, Beuth J, van Leendert R, Schneider B, Scherbaum WA.

Diabetologia. 2003 Dec;46(12):1611-7. Epub 2003 Nov 5.

PMID:
14600814
16.

Benefits of combination therapy of insulin and oral hypoglycemic agents.

Garber AJ.

Arch Intern Med. 2003 Aug 11-25;163(15):1781-2. No abstract available.

PMID:
12912710
17.

Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience.

Massi-Benedetti M.

Clin Ther. 2003 Mar;25(3):799-816. Review.

PMID:
12852703
18.

Effects of glimepiride on HbA(1c) and body weight in Type 2 diabetes: results of a 1.5-year follow-up study.

Weitgasser R, Lechleitner M, Luger A, Klingler A.

Diabetes Res Clin Pract. 2003 Jul;61(1):13-9.

PMID:
12849919
19.
20.

Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.

Overkamp D, Volk A, Maerker E, Heide PE, Wahl HG, Rett K, Häring HU.

Diabetes Care. 2002 Nov;25(11):2065-73.

PMID:
12401758

Supplemental Content

Support Center